Free Trial

ICON Public (ICLR) Insider Trading & Ownership

ICON Public logo
$203.67 +8.07 (+4.13%)
(As of 11/20/2024 ET)

There is no recent insider trading on record for ICON Public, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get ICLR Insider Trade Alerts

Want to know when executives and insiders are buying or selling ICON Public stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ICON Public Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
9/4/2024John JamesU.S. Congress Member (R-MI)Sell$312.52$1,001 - $15,000
6/12/2024John JamesU.S. Congress Member (R-MI)Buy$319.78$1,001 - $15,000
1/31/2023Kevin HernU.S. Congress Member (R-OK)Sell$230.71$1,001 - $15,000
(Data available from 1/1/2013 forward)

ICLR Insider Trading Activity - Frequently Asked Questions

44.00% of ICON Public stock is owned by insiders. Learn more on ICLR's insider holdings.

John James (R-MI) has bought shares of ICON Public in the last year totaling $8,000. John James (R-MI) has sold shares totaling $8,000.

ICON Public Key Executives

  • Dr. Steven A. Cutler MBA (Age 64)
    Ph.D., CEO & Director
    Compensation: $2.59M
  • Dr. John Climax Ph.D. (Age 71)
    Founder & Independent Non-Executive Director
    Compensation: $90k
  • Jonathan Andrew Curtain (Age 48)
    Senior Vice President of Corporate & Commercial Finance
  • Mr. Thomas N. O'Leary
    Chief Information Officer
  • Mr. Diarmaid Cunningham (Age 49)
    Chief Administrative Officer, General Counsel & Company Secretary
  • Ms. Niamh Murphy
    Director of Corporate Communications
  • Mr. David Green
    Vice President of Marketing
  • Mr. Joe Cronin
    Chief Human Resources Officer
  • Mr. Simon Holmes (Age 57)
    President of Corporate Investments & Partnerships
  • Dr. Gary Curtis
    Senior Vice President of Global Clinical Pharmacology


This page (NASDAQ:ICLR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners